Home

Recent Articles from StockStory

StockStory is a financial technology company dedicated to simplifying profitable stock investing for individual investors. By leveraging advanced AI technology and human expertise, it generates detailed, data-driven research reports and monthly stock picks to identify high-quality stocks with strong growth potential. The company aims to democratize access to sophisticated analytical methods and proprietary datasets—previously exclusive to elite hedge funds—delivering clear, actionable insights rather than complex, do-it-yourself tools. With a mission to level the playing field in a market often favoring large institutions, StockStory provides retail investors with the resources to make informed, market-beating investment decisions.

Why Rivian (RIVN) Shares Are Getting Obliterated Today
Shares of electric vehicle manufacturer Rivian (NASDAQ:RIVN) fell 6.9% in the morning session after the company reported weak first-quarter vehicle deliveries of 8,640 units, marking a 36% decline compared to the same period in the previous year. While the delivery figure matched both internal guidance and market expectations, the sharp drop hinted at demand and/or production challenges. The company also reaffirmed its full-year 2025 delivery guidance of 46,000 to 51,000 vehicles. However, the lack of an upward revision likely dampened investor sentiment.
Via StockStory · April 2, 2025
Why nCino (NCNO) Stock Is Nosediving
Shares of bank software company nCino (NASDAQ:NCNO) fell 34.3% in the after-market session after the company reported weak fourth quarter 2024 (fiscal 2025) results as its revenue and EPS guidance for next year fell short of Wall Street's estimates. The quarter was underwhelming, with sales roughly in line with expectations, while earnings missed by a wide margin. The results revealed a continued struggle to turn a profit and manage cash burn, while the guidance suggested a sharp slowdown in growth. Overall, this was a softer quarter.
Via StockStory · April 2, 2025
Why Are Sportsman's Warehouse (SPWH) Shares Soaring Today
Shares of outdoor specialty retailer Sportsman's Warehouse (NASDAQ:SPWH) jumped 109% in the morning session after the company reported impressive fourth quarter 2024 results, which blew past analysts' revenue, EPS, and EBITDA expectations. 
Via StockStory · April 2, 2025
3 Stocks Under $50 Walking a Fine Line
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
Via StockStory · April 2, 2025
3 Russell 2000 Stocks in the Doghouse
Small-cap stocks in the Russell 2000 can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
Via StockStory · April 2, 2025
3 Small-Cap Stocks Walking a Fine Line
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Via StockStory · April 2, 2025
3 Small-Cap Stocks in the Doghouse
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Via StockStory · April 2, 2025
3 Russell 2000 Stocks Skating on Thin Ice
The Russell 2000 is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Via StockStory · April 2, 2025
1 Healthcare Stock with Exciting Potential and 2 to Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 9.5%. This drop was worse than the S&P 500’s 2.3% loss.
Via StockStory · April 2, 2025
1 Services Stock on Our Watchlist and 2 to Turn Down
Business services providers use their specialized expertise to help enterprises streamline operations and cut costs. But increasing competition from AI-driven upstarts has tempered enthusiasm, and over the past six months, the industry has pulled back by 3.7%. This performance was similar to the S&P 500’s decline.
Via StockStory · April 2, 2025
3 Restaurant Stocks Walking a Fine Line
Restaurants increase convenience and give many people a place to unwind. Still, their demand can ebb and flow with the broader economy because consumers can always cook meals at home when times are tough, and the market seems to be baking in a downturn for the industry - over the past six months, it has pulled back by 6.6%. This performance was worse than the S&P 500’s 2.3% fall.
Via StockStory · April 2, 2025
UniFirst (NYSE:UNF) Posts Q1 Sales In Line With Estimates
Workplace uniform provider UniFirst (NYSE:UNF) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.9% year on year to $602.2 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $2.43 billion at the midpoint. Its GAAP profit of $1.10 per share was 8% below analysts’ consensus estimates.
Via StockStory · April 2, 2025
Earnings To Watch: Lindsay (LNN) Reports Q1 Results Tomorrow
Agricultural and farm machinery company Lindsay (NYSE:LNN) will be reporting results tomorrow before the bell. Here’s what you need to know.
Via StockStory · April 2, 2025
Acuity Brands (AYI) Reports Earnings Tomorrow: What To Expect
Intelligent lighting and space solutions provider Acuity Brands (NYSE:AYI) will be reporting results tomorrow morning. Here’s what to look for.
Via StockStory · April 2, 2025
MSC Industrial (MSM) Q1 Earnings: What To Expect
Industrial supplies company MSC Industrial Direct (NYSE:MSM) will be reporting earnings tomorrow morning. Here’s what investors should know.
Via StockStory · April 2, 2025
Guess Earnings: What To Look For From GES
Contemporary clothing brand Guess (NYSE:GES) will be reporting results tomorrow after market close. Here’s what to expect.
Via StockStory · April 2, 2025
Conagra (CAG) Q1 Earnings: What To Expect
Packaged foods company Conagra Brands (NYSE:CAG) will be reporting earnings tomorrow before market open. Here’s what to look for.
Via StockStory · April 2, 2025
What To Expect From Lamb Weston’s (LW) Q1 Earnings
Potato products company Lamb Weston (NYSE:LW) will be announcing earnings results tomorrow before market hours. Here’s what you need to know.
Via StockStory · April 2, 2025
Leisure Products Stocks Q4 Recap: Benchmarking Polaris (NYSE:PII)
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the leisure products industry, including Polaris (NYSE:PII) and its peers.
Via StockStory · April 2, 2025
3 Reasons We’re Fans of O'Reilly (ORLY)
O'Reilly currently trades at $1,425 and has been a dream stock for shareholders. It’s returned 370% since April 2020, tripling the S&P 500’s 122% gain. The company has also beaten the index over the past six months as its stock price is up 23.4%.
Via StockStory · April 2, 2025
Defense Contractors Stocks Q4 Earnings Review: Mercury Systems (NASDAQ:MRCY) Shines
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Mercury Systems (NASDAQ:MRCY) and the best and worst performers in the defense contractors industry.
Via StockStory · April 2, 2025
3 Reasons to Sell NATR and 1 Stock to Buy Instead
Although the S&P 500 is down 1.6% over the past six months, Nature's Sunshine’s stock price has fallen further to $11.31, losing shareholders 14.1% of their capital. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Via StockStory · April 2, 2025
Q4 Earnings Roundup: Photronics (NASDAQ:PLAB) And The Rest Of The Semiconductor Manufacturing Segment
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the semiconductor manufacturing industry, including Photronics (NASDAQ:PLAB) and its peers.
Via StockStory · April 2, 2025
3 Reasons GO is Risky and 1 Stock to Buy Instead
Over the past six months, Grocery Outlet’s shares (currently trading at $13.56) have posted a disappointing 19.3% loss while the S&P 500 was down 1.6%. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
Reflecting On Data & Business Process Services Stocks’ Q4 Earnings: CoStar (NASDAQ:CSGP)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the data & business process services stocks, including CoStar (NASDAQ:CSGP) and its peers.
Via StockStory · April 2, 2025
A Look Back at Air Freight and Logistics Stocks’ Q4 Earnings: C.H. Robinson Worldwide (NASDAQ:CHRW) Vs The Rest Of The Pack
Looking back on air freight and logistics stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including C.H. Robinson Worldwide (NASDAQ:CHRW) and its peers.
Via StockStory · April 2, 2025
Crane (CR): Buy, Sell, or Hold Post Q4 Earnings?
Since October 2024, Crane has been in a holding pattern, posting a small loss of 1.1% while floating around $154.84.
Via StockStory · April 2, 2025
Q4 Earnings Roundup: Brookdale (NYSE:BKD) And The Rest Of The Senior Health, Home Health & Hospice Segment
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the senior health, home health & hospice industry, including Brookdale (NYSE:BKD) and its peers.
Via StockStory · April 2, 2025
3 Reasons to Avoid IPGP and 1 Stock to Buy Instead
Over the last six months, IPG Photonics shares have sunk to $63.58, producing a disappointing 13.1% loss - worse than the S&P 500’s 1.6% drop. This may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
Leisure Facilities Stocks Q4 Highlights: Topgolf Callaway (NYSE:MODG)
Let’s dig into the relative performance of Topgolf Callaway (NYSE:MODG) and its peers as we unravel the now-completed Q4 leisure facilities earnings season.
Via StockStory · April 2, 2025
Winners And Losers Of Q4: Mohawk Industries (NYSE:MHK) Vs The Rest Of The Home Furnishings Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Mohawk Industries (NYSE:MHK) and the rest of the home furnishings stocks fared in Q4.
Via StockStory · April 2, 2025
3 Reasons NUS is Risky and 1 Stock to Buy Instead
Nu Skin has been treading water for the past six months, recording a small return of 1.6% while holding steady at $6.98.
Via StockStory · April 2, 2025
Home Construction Materials Stocks Q4 In Review: Griffon (NYSE:GFF) Vs Peers
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Griffon (NYSE:GFF) and the rest of the home construction materials stocks fared in Q4.
Via StockStory · April 2, 2025
3 Reasons Investors Love Rollins (ROL)
While the broader market has struggled with the S&P 500 down 1.6% since October 2024, Rollins has surged ahead as its stock price has climbed by 8.4% to $54.59 per share. This performance may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
Beverages, Alcohol, and Tobacco Stocks Q4 In Review: Coca-Cola (NYSE:KO) Vs Peers
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the beverages, alcohol, and tobacco stocks, including Coca-Cola (NYSE:KO) and its peers.
Via StockStory · April 2, 2025
Q4 Earnings Outperformers: AMN Healthcare Services (NYSE:AMN) And The Rest Of The Healthcare Providers & Services Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including AMN Healthcare Services (NYSE:AMN) and its peers.
Via StockStory · April 2, 2025
Q4 Earnings Highs And Lows: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks
Let’s dig into the relative performance of agilon health (NYSE:AGL) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season.
Via StockStory · April 2, 2025
MACOM (MTSI): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, MACOM’s shares (currently trading at $100.51) have posted a disappointing 7.4% loss while the S&P 500 was down 1.6%. This might have investors contemplating their next move.
Via StockStory · April 2, 2025
Pure Storage (NYSE:PSTG) Q4 Earnings: Leading The Hardware & Infrastructure Pack
Looking back on hardware & infrastructure stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Pure Storage (NYSE:PSTG) and its peers.
Via StockStory · April 2, 2025
Home Builders Stocks Q4 Results: Benchmarking Meritage Homes (NYSE:MTH)
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the home builders industry, including Meritage Homes (NYSE:MTH) and its peers.
Via StockStory · April 2, 2025
Q4 Earnings Highs And Lows: Manhattan Associates (NASDAQ:MANH) Vs The Rest Of The Vertical Software Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at vertical software stocks, starting with Manhattan Associates (NASDAQ:MANH).
Via StockStory · April 2, 2025
Reflecting On Specialty Retail Stocks’ Q4 Earnings: Petco (NASDAQ:WOOF)
Let’s dig into the relative performance of Petco (NASDAQ:WOOF) and its peers as we unravel the now-completed Q4 specialty retail earnings season.
Via StockStory · April 2, 2025
Unpacking Q4 Earnings: Robert Half (NYSE:RHI) In The Context Of Other Professional Staffing & HR Solutions Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the professional staffing & hr solutions industry, including Robert Half (NYSE:RHI) and its peers.
Via StockStory · April 2, 2025
2 Reasons to Like HUBB and 1 to Stay Skeptical
Hubbell has gotten torched over the last six months - since October 2024, its stock price has dropped 22.3% to $332.12 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
Q4 Rundown: Blink Charging (NASDAQ:BLNK) Vs Other Renewable Energy Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the renewable energy industry, including Blink Charging (NASDAQ:BLNK) and its peers.
Via StockStory · April 2, 2025
2 Reasons to Like GRC (and 1 Not So Much)
Although the S&P 500 is down 1.6% over the past six months, Gorman-Rupp’s stock price has fallen further to $35.58, losing shareholders 8.9% of their capital. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Via StockStory · April 2, 2025
Sit-Down Dining Stocks Q4 Recap: Benchmarking Bloomin' Brands (NASDAQ:BLMN)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at sit-down dining stocks, starting with Bloomin' Brands (NASDAQ:BLMN).
Via StockStory · April 2, 2025
3 Reasons We Love Sprouts (SFM)
What a time it’s been for Sprouts. In the past six months alone, the company’s stock price has increased by a massive 40%, reaching $155 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
3 Reasons to Avoid HAE and 1 Stock to Buy Instead
Haemonetics has gotten torched over the last six months - since October 2024, its stock price has dropped 20.1% to $63.39 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Via StockStory · April 2, 2025
Winners And Losers Of Q4: BJ's (NASDAQ:BJRI) Vs The Rest Of The Sit-Down Dining Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the sit-down dining industry, including BJ's (NASDAQ:BJRI) and its peers.
Via StockStory · April 2, 2025
Spotting Winners: APi (NYSE:APG) And Construction and Maintenance Services Stocks In Q4
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the construction and maintenance services industry, including APi (NYSE:APG) and its peers.
Via StockStory · April 2, 2025
2 Reasons to Sell PRVA and 1 Stock to Buy Instead
Even during a down period for the markets, Privia Health has gone against the grain, climbing to $22.91. Its shares have yielded a 29.3% return over the last six months, beating the S&P 500 by 30.9%. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Collegium Pharmaceutical (NASDAQ:COLL) and the rest of the branded pharmaceuticals stocks fared in Q4.
Via StockStory · April 2, 2025
Waste Management (WM): Buy, Sell, or Hold Post Q4 Earnings?
While the broader market has struggled with the S&P 500 down 1.7% since October 2024, Waste Management has surged ahead as its stock price has climbed by 13% to $234.23 per share. This performance may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
3 Reasons to Sell WYNN and 1 Stock to Buy Instead
Over the past six months, Wynn Resorts’s shares (currently trading at $83.10) have posted a disappointing 18.6% loss while the S&P 500 was down 1.7%. This may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
2 Reasons to Watch KRT and 1 to Stay Cautious
Karat Packaging has been treading water for the past six months, recording a small return of 4.2% while holding steady at $26.44. However, the stock is beating the S&P 500’s 1.7% decline during that period.
Via StockStory · April 2, 2025
Winners And Losers Of Q4: CBRE (NYSE:CBRE) Vs The Rest Of The Real Estate Services Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how real estate services stocks fared in Q4, starting with CBRE (NYSE:CBRE).
Via StockStory · April 2, 2025
Q4 Rundown: Elevance Health (NYSE:ELV) Vs Other Health Insurance Providers Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Elevance Health (NYSE:ELV) and the rest of the health insurance providers stocks fared in Q4.
Via StockStory · April 2, 2025
Appian (APPN): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Appian’s shares (currently trading at $28.55) have posted a disappointing 16.2% loss while the S&P 500 was down 1.7%. This may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
3 Reasons NXPI is Risky and 1 Stock to Buy Instead
The past six months haven’t been great for NXP Semiconductors. It just made a new 52-week low of $188.11, and shareholders have lost 20.1% of their capital. This may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
3 Reasons DUOL Has Explosive Upside Potential
While the broader market has struggled with the S&P 500 down 1.7% since October 2024, Duolingo has surged ahead as its stock price has climbed by 14.5% to $326.71 per share. This performance may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
2 Reasons to Like YUM and 1 to Stay Skeptical
While the broader market has struggled with the S&P 500 down 1.7% since October 2024, Yum! Brands has surged ahead as its stock price has climbed by 13.6% to $158.53 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
Spotting Winners: Wabtec (NYSE:WAB) And Heavy Transportation Equipment Stocks In Q4
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how heavy transportation equipment stocks fared in Q4, starting with Wabtec (NYSE:WAB).
Via StockStory · April 2, 2025
Q4 Earnings Outperformers: Napco (NASDAQ:NSSC) And The Rest Of The Specialized Technology Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at specialized technology stocks, starting with Napco (NASDAQ:NSSC).
Via StockStory · April 2, 2025
Netflix (NFLX): 3 Reasons We Love This Stock
In a sliding market, Netflix has defied the odds, trading up to $924.52 per share. Its 30% gain since October 2024 has outpaced the S&P 500’s 1.7% drop. This performance may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
Sales And Marketing Software Stocks Q4 In Review: Semrush (NYSE:SEMR) Vs Peers
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Semrush (NYSE:SEMR) and the rest of the sales and marketing software stocks fared in Q4.
Via StockStory · April 2, 2025
3 Reasons CDW is Risky and 1 Stock to Buy Instead
Shareholders of CDW would probably like to forget the past six months even happened. The stock dropped 26.3% and now trades at $161.66. This might have investors contemplating their next move.
Via StockStory · April 2, 2025
Travel and Vacation Providers Stocks Q4 Teardown: Choice Hotels (NYSE:CHH) Vs The Rest
Looking back on travel and vacation providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Choice Hotels (NYSE:CHH) and its peers.
Via StockStory · April 2, 2025
3 Reasons to Avoid LIND and 1 Stock to Buy Instead
While the broader market has struggled with the S&P 500 down 1.7% since October 2024, Lindblad Expeditions has surged ahead as its stock price has climbed by 14.6% to $10.28 per share. This performance may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
3 Reasons to Avoid MAR and 1 Stock to Buy Instead
Marriott has been treading water for the past six months, recording a small loss of 4.8% while holding steady at $237.
Via StockStory · April 2, 2025
3 Reasons to Sell GDEN and 1 Stock to Buy Instead
Over the last six months, Golden Entertainment shares have sunk to $26.44, producing a disappointing 14.8% loss - worse than the S&P 500’s 1.7% drop. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
3 Reasons to Sell ARCO and 1 Stock to Buy Instead
Over the past six months, Arcos Dorados’s shares (currently trading at $8.42) have posted a disappointing 14.6% loss while the S&P 500 was down 1.7%. This might have investors contemplating their next move.
Via StockStory · April 2, 2025
Rogers (ROG): Buy, Sell, or Hold Post Q4 Earnings?
What a brutal six months it’s been for Rogers. The stock has dropped 38.6% and now trades at a new 52-week low of $66.64, rattling many shareholders. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Via StockStory · April 2, 2025
3 Reasons to Avoid CSGS and 1 Stock to Buy Instead
In a sliding market, CSG has defied the odds, trading up to $60.37 per share. Its 27% gain since October 2024 has outpaced the S&P 500’s 1.7% drop. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Via StockStory · April 2, 2025
3 Big Reasons to Love Copart (CPRT)
Since April 2020, the S&P 500 has delivered a total return of 122%. But one standout stock has more than doubled the market - over the past five years, Copart has surged 253% to $56.82 per share. Its momentum hasn’t stopped as it’s also gained 7.9% in the last six months thanks to its solid quarterly results, beating the S&P by 9.6%.
Via StockStory · April 2, 2025